Increased Risk of Acute Myeloid Leukemia in Patients with <i>CYP</i>1<i>A</i>1 Polymorphisms

Journals Menu

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Journal of Cancer Therapy

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.org/journal/jct
E-mail: jct@scirp.org

Citations h5-index & Ranking

Journals Menu

"Increased Risk of Acute Myeloid Leukemia in Patients with CYP1A1 Polymorphisms"
written by Luís Arthur Flores Pelloso, Ismael Dale Cotrim Guerreiro da Silva, Naiara Côrrea Nogueira de Souza, Mihoko Yamamoto, Maria de Lourdes L. Ferrari Chauffaille,
published by Journal of Cancer Therapy, Vol.4 No.5, 2013

has been cited by the following article(s):

Google Scholar
CrossRef

[1]	Association between WT1 and MEG3 polymorphisms and risk of acute myeloid leukemia
	2020

[2]	Association of CYP3A5* 3 and CYP1A1* 2C Polymorphism with Development of Acute Myeloid Leukemia in Egyptian Patients
	Asian Pacific Journal of Cancer Prevention, 2017

[3]	Association of The Common CYP1A1* 2C Variant (Ile462Val Polymorphism) with Chronic Myeloid Leukemia (CML) in Patients Undergoing Imatinib Therapy
	Cell Journal (Yakhteh), 2015

[4]	Suppressive effects of resveratrol treatment on the intrinsic evoked excitability of CA1 pyramidal neurons
	2015

[1]	Evidence for Hesperidin as an Effective Factor in Initiating the Intrinsic Pathway of Apoptosis in KG1a Leukemia Cells International Journal of Toxicology, 2023 DOI:10.1177/10915818221146468

[2]	Evidence for Hesperidin as an Effective Factor in Initiating the Intrinsic Pathway of Apoptosis in KG1a Leukemia Cells International Journal of Toxicology, 2022 DOI:10.1177/10915818221146468

[3]	Evidence for Hesperidin as an Effective Factor in Initiating the Intrinsic Pathway of Apoptosis in KG1a Leukemia Cells International Journal of Toxicology, 2022 DOI:10.1177/10915818221146468

[4]	Association between WT1 and MEG3 polymorphisms and risk of acute myeloid leukemia Meta Gene, 2020 DOI:10.1016/j.mgene.2019.100636

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Journal of Cancer Therapy

Journal of Cancer Therapy

Journals Menu

Home

About SCIRP

Service

Policies